Compare Stocks › ABBV vs GL

AbbVie Inc. (ABBV) vs Globe Life Inc. (GL): Which Is the Better Buy in 2026?

As of 2026-11-01, ABBV is overvalued at $295, with a DCF intrinsic value of $172 and a margin of safety of -71%. GL is overvalued at $159, with an intrinsic value of $0 and a margin of safety of -100%. Of the two, ABBV has the wider margin of safety.

ABBV
AbbVie Inc.
$294.89
VS
GL
Globe Life Inc.
$159.08

Rewards

ABBV
  • ★AbbVie Inc. has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • ★Gross margin of 73.7% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • ★AbbVie Inc. scores 82/100 on the Economic Moat Score (Wide Moat), with reinvestment efficiency as the strongest competitive dimension.
GL
  • ★Globe Life Inc. scores 97/100 on the Economic Moat Score (Wide Moat), with revenue predictability as the strongest competitive dimension.
  • ★Share count has been reduced by 18% over the past 4 years through buybacks, increasing each share's claim on earnings.
  • ★Management has timed buybacks well — 3 out of 4 years showed value-accretive repurchases.

Risks

ABBV
  • ⚠Buybacks have been poorly timed — 3 out of 4 years involved repurchases at relatively expensive valuations.
  • ⚠Insiders have sold $8.2M worth of stock in the past 3 months — significant insider liquidation.
  • ⚠Free cash flow has declined at a 9.8% CAGR over the past 4 years — a concerning trend.
GL
  • ⚠Altman Z-Score of 0.85 places the company in the distress zone — financial patterns resemble those of companies that experienced bankruptcy.
  • ⚠Insiders have sold $3.9M worth of stock in the past 3 months — significant insider liquidation.

Key Valuation Metrics

Learn more →
ABBV
GL
Valuation
N/A
Free Cash Flow
N/A
N/A
FCF Yield
N/A
50.67
Trailing P/E
10.65
18.24
Forward P/E
9.71
Quality & Moat
29.08%
ROIC
15.53%
N/A
ROE
18.86%
73.72%
Gross Margin
33.10%
0.60
PEG Ratio
1.30
Balance Sheet Safety
N/A
Net Debt / Equity
0.48
N/A
Interest Coverage
N/A
2.03
Net Debt / EBITDA
1.80
2.35%
Dividend Yield
0.83%
ABBV: 4Ties: 1GL: 3
ABBVGL

Historical Fundamentals

Learn more →
ABBV

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

GL

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
ABBV
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-19.85B
Δ Market Cap
+$118.02B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
GL
$-0.20
created per $1 retained over 3 years
Market Cap Declined
Σ Retained
$2.95B
Δ Market Cap
$-600.0M
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
ABBV
71.5% Overvalued
Price is 71.5% above estimated fair value
Current Price: $294.89
Fair Value: $172.00
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
GL
Insufficient Data
Enter initial FCF to calculate intrinsic value
Current Price: $159.08
Fair Value: $0.00
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
ABBV

Requires positive FCF to compute implied growth rate.

GL

Requires positive FCF to compute implied growth rate.

Economic Moat Score

Learn more →
ABBV
82/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Reinvestment Efficiency is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
GL
97/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat driven primarily by revenue predictability. Margin Stability is the area most vulnerable to competitive pressure.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

Forensic Accounting

Learn more →
ABBV
-2.86
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
GL
-2.46
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
ABBV
Insiders 0.1%Institutions 77.4%Retail & Other 22.5%
No. of Institutional Holders5,303
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
GL
Insiders 0.7%Institutions 89.8%Retail & Other 9.5%
No. of Institutional Holders973
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
ABBV
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises
GL
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
ABBV
1
Sells (3M)
4
Sells (12M)
Total value (12M): $18.92M
DONOGHOE NICHOLAS
Officer
$8.18M
@ $250.00 · 2026-08-14
PURDUE DAVID RYAN
Officer
$1.22M
@ $233.56 · 2026-03-04
SIATIS PERRY C.
General Counsel
$4.38M
@ $234.39 · 2026-03-02
SIATIS PERRY C.
General Counsel
$5.15M
@ $230.00 · 2026-02-25
SALEKI-GERHARDT AZITA
Chief Operating Officer
$8.41M
@ $198.42 · 2025-08-12
DONOGHOE NICHOLAS
Officer
$2.64M
@ $198.51 · 2025-08-05
STEWART JEFFREY RYAN
Officer
$12.36M
@ $210.08 · 2025-03-31
REENTS SCOTT T.
Chief Financial Officer
$3.75M
@ $212.34 · 2025-03-14
GONZALEZ RICHARD A
Director
$20.26M
@ $205.45 · 2025-03-03
RICHMOND TIMOTHY J
Officer
$4.47M
@ $210.45 · 2025-03-03
SIATIS PERRY C.
General Counsel
$5.82M
@ $208.69 · 2025-03-03
RICHMOND TIMOTHY J
Officer
$6.07M
@ $202.90 · 2025-02-26
BUCKBEE KEVIN K
Officer
$3.85M
@ $203.41 · 2025-02-26
SIATIS PERRY C.
General Counsel
$1.14M
@ $197.90 · 2025-02-20
BUCKBEE KEVIN K
Officer
$310,032
@ $172.24 · 2024-12-16
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
GL
2
Sells (3M)
35
Sells (12M)
Total value (12M): $78.33M
MAJORS MICHAEL CLAY
Officer
$2.22M
@ $154.48 · 2026-10-23
HENSLEY ROBERT EDWARD
Chief Investment Officer
$1.70M
@ $170.07 · 2026-09-22
DARDEN JAMES MATTHEW
Chief Executive Officer
$9.12M
@ $182.43 · 2026-07-31
KALMBACH THOMAS PETER
Chief Financial Officer
$3.78M
@ $180.06 · 2026-07-30
MAJORS MICHAEL CLAY
Officer
$6.61M
@ $178.64 · 2026-07-29
KALMBACH THOMAS PETER
Chief Financial Officer
$4.58M
@ $178.58 · 2026-07-28
SKARJUNE DOLORES L
Officer
$331,483
@ $179.18 · 2026-06-30
ALSTON CHERYL D
Director
$1.48M
@ $179.24 · 2026-06-25
ZORN REBECCA E
Officer
$340,193
@ $170.10 · 2026-06-18
SVOBODA FRANK M
Chief Executive Officer
$3.32M
@ $165.78 · 2026-06-12
SKARJUNE DOLORES L
Officer
$693,794
@ $166.18 · 2026-06-12
SVOBODA FRANK M
Chief Executive Officer
$3.13M
@ $156.68 · 2026-05-22
KALMBACH THOMAS PETER
Chief Financial Officer
$1.24M
@ $156.59 · 2026-05-22
KALMBACH THOMAS PETER
Chief Financial Officer
$1.86M
@ $156.61 · 2026-05-19
KALMBACH THOMAS PETER
Chief Financial Officer
$4.20M
@ $152.95 · 2026-05-11
HENRIE MICHAEL SHANE
Officer
$333,656
@ $155.19 · 2026-05-06
SVOBODA FRANK M
Chief Executive Officer
$2.30M
@ $153.59 · 2026-05-05
DARDEN JAMES MATTHEW
Chief Executive Officer
$3.39M
@ $153.85 · 2026-05-05
SVOBODA FRANK M
Chief Executive Officer
$1.54M
@ $153.75 · 2026-05-01
DARDEN JAMES MATTHEW
Chief Executive Officer
$717,530
@ $153.88 · 2026-04-28
MAJORS MICHAEL CLAY
Officer
$5.23M
@ $153.81 · 2026-04-24
HENRIE MICHAEL SHANE
Officer
$555,168
@ $154.60 · 2026-04-24
ZORN REBECCA E
Officer
$1.20M
@ $136.61 · 2026-03-31
DARDEN JAMES MATTHEW
Chief Executive Officer
$2.66M
@ $145.10 · 2026-03-04
DARDEN JAMES MATTHEW
Chief Executive Officer
$2.66M
@ $145.10 · 2026-03-04
HENSLEY ROBERT EDWARD
Chief Investment Officer
$372,620
@ $145.04 · 2026-03-02
HENSLEY ROBERT EDWARD
Chief Investment Officer
$372,620
@ $145.04 · 2026-03-02
DARDEN JAMES MATTHEW
Chief Executive Officer
$1.38M
@ $144.34 · 2026-02-27
HAWORTH JENNIFER ALLISON
Officer
$1.53M
@ $145.29 · 2026-02-27
HENSLEY ROBERT EDWARD
Chief Investment Officer
$101,524
@ $142.59 · 2026-02-25
SVOBODA FRANK M
Chief Executive Officer
$1.81M
@ $144.78 · 2026-02-17
HAWORTH JENNIFER ALLISON
Officer
$1.43M
@ $143.14 · 2026-02-12
MAJORS MICHAEL CLAY
Officer
$4.41M
@ $146.89 · 2026-02-06
SVOBODA FRANK M
Chief Executive Officer
$1.32M
@ $140.43 · 2025-12-16
HENRIE MICHAEL SHANE
Officer
$426,341
@ $139.10 · 2025-12-12
MITCHELL ROBERT BRIAN
General Counsel
$12.22M
@ $134.28 · 2025-10-24
SKARJUNE DOLORES L
Officer
$641,340
@ $142.52 · 2025-09-12
SKARJUNE DOLORES L
Officer
$695,537
@ $139.83 · 2025-09-10
MAJORS MICHAEL CLAY
Officer
$1.37M
@ $137.41 · 2025-08-01
SVOBODA FRANK M
Chief Executive Officer
$3.54M
@ $141.58 · 2025-07-31
KALMBACH THOMAS PETER
Chief Financial Officer
$4.08M
@ $140.97 · 2025-07-29
HENRIE MICHAEL SHANE
Officer
$454,196
@ $139.75 · 2025-07-29
HENRIE MICHAEL SHANE
Officer
$454,196
@ $139.75 · 2025-07-29
DARDEN JAMES MATTHEW
Chief Executive Officer
$4.51M
@ $135.59 · 2025-07-25
ZORN REBECCA E
Officer
$2.03M
@ $135.58 · 2025-07-25
SVOBODA FRANK M
Chief Executive Officer
$733,617
@ $121.24 · 2025-06-04
SVOBODA FRANK M
Chief Executive Officer
$737,385
@ $122.51 · 2025-05-20
ZORN REBECCA E
Officer
$1.21M
@ $121.09 · 2025-05-12
HENRIE MICHAEL SHANE
Officer
$347,641
@ $126.41 · 2025-03-19
HENSLEY ROBERT EDWARD
Chief Technology Officer
$200,952
@ $124.81 · 2025-03-04
SVOBODA FRANK M
Chief Executive Officer
$2.66M
@ $122.42 · 2025-02-14
SVOBODA FRANK M
Chief Executive Officer
$1.34M
@ $121.44 · 2025-02-11
DARDEN JAMES MATTHEW
Chief Executive Officer
$3.02M
@ $121.52 · 2025-02-11
MITCHELL ROBERT BRIAN
General Counsel
$3.66M
@ $121.90 · 2025-02-07
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
ABBV
FearGreed
😏Greed(72/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
GL
FearGreed
😐Neutral(50/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
ABBV
⚪Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (72)
GL
⚪Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (50)
View ABBV Full AnalysisView GL Full Analysis

Frequently Asked Questions: ABBV vs GL

Is AbbVie Inc. or Globe Life Inc. more undervalued in 2026?▼

Based on our discounted cash flow model, ABBV trades at a -71.5% margin of safety (intrinsic value $172 vs. price $295), compared to GL's -100.0% margin of safety (intrinsic $0 vs. $159).

Which stock has a wider economic moat, AbbVie Inc. or Globe Life Inc.?▼

GL scores 97/100 (Wide moat), while ABBV scores 82/100 (Wide moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is Globe Life Inc. in financial distress?▼

GL's Altman Z-Score of 0.8 places it in the Distress zone, signaling elevated bankruptcy risk. ABBV scores 2.4 (Grey zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which stock has higher return on invested capital, AbbVie Inc. or Globe Life Inc.?▼

ABBV earns 29.1% ROIC versus GL's 15.5%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, AbbVie Inc.'s or Globe Life Inc.'s?▼

GL's dividend earns a safety score of 94/100 (Very Safe), compared to ABBV's 39/100 (Unsafe). GL has raised its dividend for 3 consecutive years.

ABBV vs GL: Which Is the Better Buy in 2026? | SafetyMargin.io